Hulin A - Search Results

1

Mycophenolate mofetil monotherapy for severe side effects of calcineurin inhibitors following liver transplantation.

Dharancy S, Iannelli A, Hulin A, Declerck N, Schneck AS, Mathurin P, Boleslawski E, Gugenheim J, Pruvot FR. Dharancy S, et al. Among authors: hulin a. Am J Transplant. 2009 Mar;9(3):610-3. doi: 10.1111/j.1600-6143.2008.02529.x. Am J Transplant. 2009. PMID: 19260838 Free article.

2

Magnesium-deficiency does not alter calcineurin inhibitors activity in mice.

Hulin A, Lamrani L, Sabbagh F, Tallet A, Lecerf F, Bac P, German-Fattal M. Hulin A, et al. Transpl Immunol. 2012 Jan;26(1):55-61. doi: 10.1016/j.trim.2011.09.001. Epub 2011 Sep 13. Transpl Immunol. 2012. PMID: 21964379

3

Deficiency in calcineurin activity in liver transplantation candidates with alcoholic cirrhosis or hepatocellular carcinoma.

Blanchet B, Hurtova M, Roudot-Thoraval F, Costentin CE, Barrault C, Jouault H, Medkour F, Laurent A, Duvoux C, Hulin A. Blanchet B, et al. Among authors: hulin a. Liver Int. 2009 Sep;29(8):1152-7. doi: 10.1111/j.1478-3231.2009.02084.x. Epub 2009 Jul 10. Liver Int. 2009. PMID: 19619265

4

Pharmacokinetic-pharmacodynamic assessment of tacrolimus in liver-transplant recipients during the early post-transplantation period.

Blanchet B, Duvoux C, Costentin CE, Barrault C, Ghaleh B, Salvat A, Jouault H, Astier A, Tod M, Hulin A. Blanchet B, et al. Among authors: hulin a. Ther Drug Monit. 2008 Aug;30(4):412-8. doi: 10.1097/FTD.0b013e318178e31b. Ther Drug Monit. 2008. PMID: 18641556

5

[Today in molecular mechanisms of immunosuppressive drugs actions: roles of pharmacist].

Hulin A. Hulin A. Ann Pharm Fr. 2008 Mar;66(2):102-14. doi: 10.1016/j.pharma.2008.03.005. Epub 2008 Jun 4. Ann Pharm Fr. 2008. PMID: 18570909 Review. French.

6

Impact of cyclosporine A on magnesium homeostasis: clinical observation in lung transplant recipients and experimental study in mice.

Sabbagh F, El Tawil Z, Lecerf F, Hulin A, Maurois P, Dartevelle P, Bac P, German-Fattal M. Sabbagh F, et al. Among authors: hulin a. Transplantation. 2008 Aug 15;86(3):436-44. doi: 10.1097/TP.0b013e31817fe069. Transplantation. 2008. PMID: 18698248

7

Adverse cutaneous reactions to the new second-generation tyrosine kinase inhibitors (dasatinib, nilotinib) in chronic myeloid leukemia.

Delgado L, Giraudier S, Ortonne N, Zehou O, Cordonnier C, Hulin A, Chosidow O, Tulliez M, Valeyrie-Allanore L. Delgado L, et al. Among authors: hulin a. J Am Acad Dermatol. 2013 Nov;69(5):839-840. doi: 10.1016/j.jaad.2013.07.025. J Am Acad Dermatol. 2013. PMID: 24124828 No abstract available.

8

Effect of hypomagnesemia on allogeneic activation in mice.

Sabbagh F, Lecerf F, Hulin A, Bac P, German-Fattal M. Sabbagh F, et al. Among authors: hulin a. Transpl Immunol. 2008 Nov;20(1-2):83-7. doi: 10.1016/j.trim.2008.07.005. Epub 2008 Aug 14. Transpl Immunol. 2008. PMID: 18707001

9

Patients' perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study.

Petitdidier N, Tannoury J, de'Angelis N, Gagniere C, Hulin A, Rotkopf H, Mesli F, Brunetti F, Sobhani I, Amiot A. Petitdidier N, et al. Among authors: hulin a. Dig Liver Dis. 2019 Dec;51(12):1652-1660. doi: 10.1016/j.dld.2019.08.020. Epub 2019 Nov 11. Dig Liver Dis. 2019. PMID: 31718934

10

Distribution of calcineurin activity in blood cell fractions and impact of tacrolimus inhibition.

Blanchet B, Hulin A, Ghaleh B, Giraudier S, Jouault H, Astier A. Blanchet B, et al. Among authors: hulin a. Fundam Clin Pharmacol. 2006 Apr;20(2):137-44. doi: 10.1111/j.1472-8206.2006.00399.x. Fundam Clin Pharmacol. 2006. PMID: 16573714

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters